Skip to main content
. 2022 Aug 26;13:921432. doi: 10.3389/fgene.2022.921432

TABLE 5.

Significant multivariable relations between patient/caregiver reports of being on hydroxyurea and provider prescription of hydroxyurea.

Model Variable Odds ratio (95%confidence interval)
Patient/Caregiver report of being on hydroxyurea
Age
 12 years and younger Reference
 13–17 years 1.9 (0.66–5.2)
 18–25 years 0.48 (0.15–1.53)
 26 years and older 0.13 (0.04–0.38)**
Total Barriers
 None Reference
 1 barrier 0.08 (0.03–0.20)***
 2 or more barriers 0.19 (0.07–0.57)*
Indication—Recurrent Pain 811.5 (87.7–7504.3)***
Not Interested in hydroxyurea 0.06 (0.01–0.31)**
Provider prescription of hydroxyurea
Age
 12 years and younger Reference
 13–17 years 1.1 (0.56–2.1)
 18–25 years 0.65 (0.33–1.30)
 26 years and older 0.45 (0.25–0.78)*
Total Barriers
 None Reference
 1 barrier 0.15 (0.09–0.26)***
 2 or more barriers 0.27 (0.14–0.52)**
Diagnosis
 HgbSS and HgbSβ0 thalassemia Reference
 HgbSC 0.21 (0.10–0.41)***
 Other diagnoses 0.35 (0.13–0.90)

*p < 0.01, **p < 0.001, ***p < 0.0001.